AI assistant
Sending…
PTC THERAPEUTICS, INC. — Director's Dealing 2014
Jan 30, 2014
31046_dirs_2014-01-30_c8668da1-df89-42fe-9c03-e2a1b08d86ce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2014-01-28
Reporting Person: Koppel Adam (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-28 | Stock Option (right to buy) | $27.05 | A | 10000 | Acquired | 2024-01-27 | Common Stock (10000) | Direct |
More from PTC THERAPEUTICS, INC.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20